4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0000899243-23-019094
Director acquired 6,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vecchiolla Thomas A. Director | 2023-09-12 | Conversion | +6,000 | 6,000 | D | ||
| Derivatives | |||||||
| Vecchiolla Thomas A. Director | 2023-09-12 | Other acquisition · Class B Common Stock, par value $0.0001 per share | +6,000 | 6,000 | D | ||
| Vecchiolla Thomas A. Director | 2023-09-12 | Conversion · Class B Common Stock, par value $0.0001 per share | −6,000 | 0 | D | ||
| Vecchiolla Thomas A. Director | 2023-09-12 | Other acquisition · Warrants | +66,667 | 66,667 | D | ||
Loading xslF345X05/doc4.xml…